Compare Maxindo Karya Anugerah Tbk. (MAXI) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maxindo Karya Anugerah Tbk. vs Merck Tbk. — how do they compare? Maxindo Karya Anugerah Tbk. trades at Rp50 (market cap 480.5B, 37.7K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 3.5× Maxindo Karya Anugerah Tbk.'s market cap, and Maxindo Karya Anugerah Tbk. is more actively traded (37.7K versus 37.6K). Which is the better fit depends on your goals.
| MAXI | MERK | |
|---|---|---|
Market Cap | 480.5B | 1.7T |
Volume | 37.7K | 37.6K |
Lot | 377 | 376 |
Turnover | 1.89M | 144.47M |
Average Price | 50 | 3,842.23 |
Value | 1.89M | 144.47M |
Indicative Equilibrium Price | 50 | 3,840 |
Indicative Equilibrium Volume | 1 | 7 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maxindo Karya Anugerah Tbk.
PT Maxindo Karya Anugerah Tbk (the Company) was established based on Notarial Deed No. 26 of Dwi Swandiani, S.H., dated July 11, 2002. The Company started its commercial operations in 2002.
Read more on MAXI →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
